Start a ProjectNEWS · RESEARCH · INDUSTRY PERSPECTIVES
On 4 September 2026 at CPI Expo in Suzhou, CASMN shared its view on the clinical progress and industrialisation pathway of microneedle delivery, alongside its RT-SMP® room-temperature printing process and CDMO capabilities.
Read the translation →
CASMN invites pharmaceutical, medical-device and healthcare partners to BIOME2026 in Beijing from 16 to 18 September 2026, presenting its flexible dissolving microneedle platform and dual-base development and manufacturing capabilities.
Read the translation →
CASMN subsidiary CASPARA won a gold award in the “Chongqing Gifts” tourism-product competition with its wrinkle-smoothing dissolving microcrystal patch, selected from more than 600 entries.
Read the translation →
This article compares conventional topical skincare, aesthetic procedures and dissolving microcrystal patches by delivery mechanism, user experience, cost and suitable use cases.
Read the translation →
A practical introduction to oral, conventional transdermal and microneedle-enabled delivery routes for sleep-related products, published for World Sleep Day.
Read the translation →
Technology, formulation, compliance and manufacturing considerations for brands evaluating dissolving microcrystal patch products after the 69th China International Beauty Expo.
Read the translation →
An overview of the delivery principle, product differentiation and industrial-development opportunities of dissolving microcrystal patches for functional skincare.
Read the translation →
This article introduces a night patch concept in the context of sleep-related concerns and discusses the value of convenient transdermal product formats.
Read the translation →
CASMN provides CRO/CDMO R&D and industrialization services for drug and medical-related projects, and ODM/OEM product-development and manufacturing services for functional-skincare products.
Read the translation →
The article explains how flexible polymer microstructures can target the stratum corneum and how room-temperature printing supports cosmetic product development and scale-up.
Read the translation →
CASMN was recognized for innovation in microneedle transdermal delivery and its contribution to differentiated functional-skincare technology.
Read the translation →
A research-focused overview of dissolving hematoporphyrin microneedles and their potential to address delivery challenges in port-wine stain treatment.
Read the translation →
CASMN’s proprietary RT-SMP® room-temperature printing process received a 2025 Ringier Technology Innovation Award in the personal-care industry.
Read the translation →
A research overview of a bilayer core–shell microneedle patch designed to support sustained drug delivery in osteoporosis treatment research.
Read the translation →
This article examines common microneedle scale-manufacturing barriers and the process strategy behind CASMN’s RT-SMP® room-temperature printing platform.
Read the translation →
CASMN received a Chinese invention patent for a brightening and pigmentation-care composition, gel, preparation method and application (ZL 2024 1 0598208.1).
Read the translation →CASMN was appointed leader of the working group responsible for drafting the Chinese group standard for dissolving microcrystal patches.
Read the translation →